Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of TRB N0224 in patients with osteoarthritis

Trial Profile

Phase I trial of TRB N0224 in patients with osteoarthritis

Phase of Trial: Phase I

Latest Information Update: 12 Sep 2014

At a glance

  • Drugs TRB N0224 (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Sep 2014 New trial record
    • 29 Jul 2014 The Feinstein Institute for Medical Research, in partnership with Traverse Biosciences, received an award from the National Institute on Aging which will support this study, according to a North Shore Long Island Jewish Health System media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top